Neubase Therapeutics, Inc.
NBSE
Revenue
0.00
0.000.00%
-Assets
18.62M
▼-3.71M▼-16.62%
3 Months ChangeLiabilities
9.48M
▼-1.60M▼-14.46%
3 Months ChangeFree Cash Flow
-3.46M
▲2.28M▲39.67%
3 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-06-27
Form 8-K
ID: 0001104659-24-075711
2024-05-31
Form 8-K
ID: 0001104659-24-067212
2024-05-22
Form 8-K
ID: 0001104659-24-064320
2024-05-13
Form 8-K
ID: 0001104659-24-060568
2024-05-03
Form 8-K
ID: 0001104659-24-056957
2024-04-05
Form 8-K
ID: 0001104659-24-044287
2024-03-07
Form 8-K
ID: 0001104659-24-031876
2024-02-23
Form 8-K
ID: 0001104659-24-027005
2024-01-26
Form 8-K
ID: 0001104659-24-007014
2024-01-17
Form 8-K
ID: 0001104659-24-004247